New research shows that the drug Riluzole, approved by the U.S. Food and Drug Administration to treat certain forms of amyotrophic lateral sclerosis, can at least partially correct the molecular cause of some leukodystrophies.

#Neuroscience #Neurology #NeurologicalDiseases #NeurodegenerativeDiseases #RareDiseases #Leukodystrophies #Demyelination #DemyelinatingDiseases #Riluzole

https://neurosciencenews.com/myelin-neuropharmacology-21997/